SkyQuest Technology Group recently introduced Infectious Disease Diagnostics Market study with in-depth overview, describing about the Product/Industry Scope and elaborates market outlook and status (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. The Infectious Disease Diagnostics Market has witnessed Excellent growth over the past decade and is expected to maintain its upward trajectory.
Infectious Disease Diagnostics Market size was valued at USD 22.6 billion in 2023 and is poised to grow from USD 24.32 billion in 2024 to USD 43.69 billion by 2032, growing at a CAGR of 7.6% during the forecast period (2025-2032).
The growing aging population worldwide and numerous untapped opportunities in developing countries are expected to boost the growth of the industry during the forecast period. According to World Bank Group estimates that in 2022 there were approximately 779 million people aged 65 & older worldwide. In addition, the number of individuals aged 80 and older is expected to more than double in 2050. The rise of infectious diseases is an important driver of rapid income. Moreover, it must be done routine screening of adults to avoid serious infections.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/infectious-disease-diagnostics-market
Increased regulatory scrutiny of the infectious disease diagnostics market as well. The regulatory framework for drug approval has always been one of the major inhibitors in the clinical research industry. The regulatory framework for the research sector is very strict in countries where the market has great potential for growth due to the large patient pool. Such sporadic and uncertain regulatory processes for in vitro diagnostics confuse manufacturers for commercial purposes.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Infectious Disease Diagnostics Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Product
Reagents, Kits, Consumables, Instruments, Software & Services
Type of Testing
Laboratory Testing, POC Testing
Sample Type
Blood, Serum, Plasma, Urine, Other Sample Types
Disease Type
Hepatitis (Hepatitis B, Hepatitis C, Other Hepatitis Diseases), HIV, Hospital-Acquired Infections, Mosquito-Borne Diseases, HPV, Chlamydia Trachomatis, Neisseria Gonorrhea, Tuberculosis, Influenza, Syphilis, Other Infectious Diseases
Technology
Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarray, Other Technologies
End User
Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, Other End Users
Infectious Disease Diagnostics Market – Regional Analysis:
– Infectious Disease Diagnostics North America Market includes (Canada, Mexico, USA)
– Infectious Disease Diagnostics Europe Market includes (Germany, France, Great Britain, Italy, Spain, Russia)
– Infectious Disease Diagnostics Asia-Pacific Market includes (China, Japan, India, South Korea, Australia)
– Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa)
– Infectious Disease Diagnostics South America Market includes (Brazil, Argentina)
– Infectious Disease Diagnostics Oceania Market (Australia & New Zealand)
Top Market Players in Infectious Disease Diagnostics Market are:
F. Hoffmann-La Roche Ltd. (Switzerland)
Abbott (US)
bioMerieux (France)
Siemens Healthineers AG (Germany)
Danaher (US)
Thermo Fisher Scientific Inc. (US)
Hologic, Inc. (US)
Becton, Dickinson and Company (US)
Revvity (US)
Qiagen (Netherlands)
Seegene Inc. (South Korea)
QuidelOrtho Corporation (US)
Grifols, S.A. (Spain)
DiaSorin S.p.A. (Italy)
Bio-Rad Laboratories, Inc. (US)
Sysmex Corporation (Japan)
OraSure Technologies (US)
Co-Diagnostics, Inc. (US)
Trinity Biotech (Ireland)
Genetic Signatures Ltd. (Australia)
Infectious Disease Diagnostics Key Market Trends:
Increase in Point-of-Care Testing (POCT): A major trend in the infectious disease diagnostics market is the rise of POCT. Changes in the decentralization of health care delivery and rapid on-demand analysis have led to the adoption of easy-to-use portable diagnostic kits. This trend does not appear to give rise to not only increases patient attendance but also reduces stress on hospitals by allowing outpatient testing.
Expansion Of Molecular Diagnostics: The widespread use of molecular diagnostics in the diagnosis of infectious diseases is another major trend. This technology provides rapid and molecularly accurate results, enabling infection to be detected even before symptoms appear. Molecular analysis plays an increasingly important role in early detection, especially in preparing for and controlling outbreaks.
Also Read –
https://www.openpr.com/news/3955666/out-of-home-advertising-market-to-evolve-with-new-age
https://pando.life/article/892612
Forward-Looking Insights
The Infectious Disease Diagnostics Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
